Fmr LLC Vir Biotechnology, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Fmr LLC holds 8,033 shares of VIR stock, worth $78,482. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,033

Previous 6,706 19.79%

Holding current value

$78,482

Previous $67,000 5.97%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$7.63 - $12.66 $10,125 - $16,799	1,327 Added 19.79%	8,033 $71,000
Q1 2024 May 13, 2024	BUY	$8.6 - $11.9 $2,863 - $3,962	333 Added 5.23%	6,706 $67,000
Q4 2023 Feb 13, 2024	SELL	$7.76 - $10.29 $1.14 Million - $1.52 Million	-147,289 Reduced 95.85%	6,373 $64,000
Q3 2023 Nov 13, 2023	SELL	$9.14 - $24.62 $970,064 - $2.61 Million	-106,134 Reduced 40.85%	153,662 $1.44 Million
Q2 2023 Aug 11, 2023	BUY	$23.2 - $27.29 $2.95 Million - $3.47 Million	127,018 Added 95.66%	259,796 $6.37 Million
Q1 2023 May 11, 2023	BUY	$22.26 - $30.85 $1.39 Million - $1.92 Million	62,328 Added 88.47%	132,778 $3.09 Million
Q4 2022 Feb 13, 2023	BUY	$19.96 - $28.22 $459,279 - $649,342	23,010 Added 48.5%	70,450 $1.78 Million
Q3 2022 Nov 10, 2022	BUY	$18.26 - $31.1 $241,853 - $411,919	13,245 Added 38.73%	47,440 $914,000
Q2 2022 Aug 12, 2022	BUY	$19.08 - $26.7 $39,362 - $55,082	2,063 Added 6.42%	34,195 $870,000
Q1 2022 May 13, 2022	SELL	$21.19 - $40.01 $5.33 Million - $10.1 Million	-251,514 Reduced 88.67%	32,132 $826,000
Q4 2021 Feb 14, 2022	BUY	$30.97 - $54.03 $8.78 Million - $15.3 Million	283,646 New	283,646 $11.9 Million
Q3 2021 Nov 15, 2021	SELL	$34.9 - $54.54 $34 - $54	-1 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$38.75 - $51.0 $38 - $51	1 New	1 $0

Others Institutions Holding VIR

# of Institutions

222

Shares Held

86.4M

Call Options Held

231K

Put Options Held

132K

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1.3B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account